公司資料
Bone Biologics 股價、新聞與催化劑
- 股票代碼:
- BBLG
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.63 USD (+3.50%)
收盤價
最後更新: 2026年8月21日
2.28M USD
市值
股價為何變動
As of Aug 21, 2026, BBLG closed up 3.50% at $0.6262. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Bone Biologics is a biotechnology company focused on bone regeneration and spinal fusion support products. Its story centers on using biologic materials to improve orthopedic healing.
所在地與產業分類
Bone Biologics is headquartered in the United States and listed on NASDAQ. It sits in regenerative medicine and orthopedic biotechnology.
商業模式特徵
The company depends on clinical and preclinical progress, product development, and the ability to create a differentiated bone-growth platform. Investors usually watch data, regulatory steps, and capital runway.
生技產業定位
Bone Biologics occupies a small orthopedic-regeneration niche within biotech. The stock is sensitive to whether its biologic platform can translate into meaningful surgical use.
未來催化劑
- Bone Biologics’ catalysts are NELL-1 / spine-regeneration work and any update that shows the platform can still progress clinically. The company remains highly dependent on proof of concept.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。